PrimXMAD:PRM -0.37%69 Days Payable is 77.39 as of Dec. 2025, which is 9% above its 10-year median of 71.10. GuruFocus rates XMAD:PRM with a GF Score™ of 69/100 and a GF Value™ of €7.12 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Prim ranks better than 54.34% on this metric.
Prim's average Accounts Payable for the
six
months ended in Dec. 2025 was €26.6 Mil. Prim's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €62.7 Mil.
Hence, Prim's Days Payable for the
six
months ended in Dec. 2025 was 77.39.
The historical rank and industry rank for Prim's Days Payable or its related term are showing as below:
XMAD:PRM'
s Days Payable Range Over the Past 10 Years
Min: 65.29 Med: 71.1 Max: 79.11
Current: 74.17
During the past 13 years, Prim's highest Days Payable was 79.11. The lowest was 65.29. And the median was 71.10.
XMAD:PRM's Days Payable is ranked better than 54.34% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs XMAD:PRM: 74.17
Prim's Days Payable
increased
from Dec. 2024 (75.29) to Dec. 2025 (77.39).
It may suggest that Primdelayed paying its suppliers.
Prim Days Payable Related Terms
Prim Days Payable Historical Data
* Premium members only.
The historical data trend for Prim's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:PRM vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Prim's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prim Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prim's Days Payable distribution charts can be found below:
* The bar in red indicates where Prim's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Prim's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prim (XMAD:PRM) has a Days Payable of 77.39 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Prim and its competitors. This is near median its historical median of 71.10. Over the past decade, Prim's Days Payable has ranged from 65.29 to 79.11. According to the industry distribution chart, Prim ranks #363 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 45.7%.
Is Prim's Days Payable too high?
Prim's current Days Payable of 77.39 is near median its 10-year median of 71.10. Over the past 10 years, this metric has ranged from a low of 65.29 to a high of 79.11. The Medical Devices & Instruments industry median Days Payable is 67.87. Prim's value of 77.39 is 14% above this industry median. Based on the distribution chart, Prim ranks #363 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Prim has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Prim's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prim ranks #363 out of 795 companies for Days Payable. This puts Prim in the upper half of its industry. The industry median Days Payable is 67.87. Prim's value of 77.39 is 14% above this benchmark. Historically, Prim's own Days Payable has ranged from 65.29 to 79.11 over the past decade. While the company's 10-year median is 71.10 vs. the industry median of 67.87, Prim has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prim's current Days Payable of 77.39 is 14% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Prim and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prim's current Days Payable is 77.39, which is near median its own 10-year median of 71.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prim stock overvalued right now?
Based on GuruFocus' analysis, Prim (XMAD:PRM) is currently considered Significantly Overvalued. The stock's GF Value™ is €7.12, compared to a current price of €13.40 — trading 88.2% above its estimated fair value. The current Days Payable is 77.39, which is near median its 10-year median of 71.10 and 14% above the Medical Devices & Instruments industry median of 67.87. Prim's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Prim (XMAD:PRM), the current Days Payable is 77.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prim (XMAD:PRM) Overvalued in 2026?
Based on GuruFocus' analysis, Prim stock appears to be overvalued.
The current stock price of €13.40 is trading 88.2% above its estimated GF Value™ of €7.12.
GuruFocus considers Prim to be Significantly Overvalued.
Key valuation signals for XMAD:PRM:
Days Payable: 77.39 (near median its 10-year median of 71.10)
GF Value™: €7.12 vs. price of €13.40 (88.2% above fair value)
Industry Position: 14% above the Medical Devices & Instruments median (#363 of 795)
No single metric tells the full story. See the XMAD:PRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
69GF Score
Get the complete analysis for XMAD:PRM
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:PRM has been successfully added to your 
